A Framework for Demonstrating Practical Quantum Advantage: Racing Quantum against Classical Generative Models

Generative modeling has seen a rising interest in both classical and quantum machine learning, and it represents a promising candidate to obtain a practical quantum advantage in the near term. In this study, we build over a proposed framework for evaluating the generalization performance of generative models, and we establish the first quantitative comparative race towards practical quantum advantage (PQA) between classical and quantum generative models, namely Quantum Circuit Born Machines (QCBMs), Transformers (TFs), Recurrent Neural Networks (RNNs), Variational Autoencoders (VAEs), and Wasserstein Generative Adversarial Networks (WGANs). After defining four types of PQAs scenarios, we focus on what we refer to as potential PQA, aiming to compare quantum models with the best-known classical algorithms for the task at hand. We let the models race on a well-defined and application-relevant competition setting, where we illustrate and demonstrate our framework on 20 variables (qubits) generative modeling task. Our results suggest that QCBMs are more efficient in the data-limited regime than the other state-of-the-art classical generative models. Such a feature is highly desirable in a wide range of real-world applications where the available data is scarce.Comment: 17 pages, 5 figures, 3 table

DeepGraphMol, a multi-objective, computational strategy for generating molecules with desirable properties: a graph convolution and reinforcement learning approach

Abstract We address the problem of generating novel molecules with desired interaction properties as a multi-objective optimization problem. Interaction binding models are learned from binding data using graph convolution networks (GCNs). Since the experimentally obtained property scores are recognised as having potentially gross errors, we adopted a robust loss for the model. Combinations of these terms, including drug likeness and synthetic accessibility, are then optimized using reinforcement learning based on a graph convolution policy approach. Some of the molecules generated, while legitimate chemically, can have excellent drug-likeness scores but appear unusual. We provide an example based on the binding potency of small molecules to dopamine transporters. We extend our method successfully to use a multi-objective reward function, in this case for generating novel molecules that bind with dopamine transporters but not with those for norepinephrine. Our method should be generally applicable to the generation in silico of molecules with desirable properties